Terms: = Prostate cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
12 results:
1. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
2. METTL3 preferentially enhances non-m
Wei X; Huo Y; Pi J; Gao Y; Rao S; He M; Wei Q; Song P; Chen Y; Lu D; Song W; Liang J; Xu L; Wang H; Hong G; Guo Y; Si Y; Xu J; Wang X; Ma Y; Yu S; Zou D; Jin J; Wang F; Yu J
Nat Cell Biol; 2022 Aug; 24(8):1278-1290. PubMed ID: 35927451
[TBL] [Abstract] [Full Text] [Related]
3. [Role of eukaryotic translation initiation factor 4G in tumor].
Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
[TBL] [Abstract] [Full Text] [Related]
4. Anaesthetic techniques for risk of malignant tumour recurrence.
Cakmakkaya OS; Kolodzie K; Apfel CC; Pace NL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008877. PubMed ID: 25379840
[TBL] [Abstract] [Full Text] [Related]
5. Long-term survival in a Swedish population-based cohort of men with prostate cancer.
Sandblom G; Dufmats M; Varenhorst E
Urology; 2000 Sep; 56(3):442-7. PubMed ID: 10962312
[TBL] [Abstract] [Full Text] [Related]
6. Follow-up of localized prostate cancer, with emphasis on previous undiagnosed incidental cancer.
Berner A; Harvei S; Skjorten FJ
BJU Int; 1999 Jan; 83(1):47-52. PubMed ID: 10233451
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer.
Arcangeli G; Micheli A; Verna L; Saracino B; Arcangeli G; Giovinazzo G; D'Angelo L; Pansadoro V; Sternberg CN
Radiother Oncol; 1995 May; 35(2):123-8. PubMed ID: 7569020
[TBL] [Abstract] [Full Text] [Related]
8. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.
Lundberg S; Carstensen J; Rundquist I
Cancer Res; 1987 Apr; 47(7):1973-7. PubMed ID: 3815387
[TBL] [Abstract] [Full Text] [Related]
9. Primary site as a prognostic variable for children with pelvic soft tissue sarcomas.
Raney B; Carey A; Snyder HM; Duckett JW; Schnaufer L; Rosenberg HK; Mahboubi S; Chatten J; Littman P
J Urol; 1986 Oct; 136(4):874-8. PubMed ID: 3761449
[TBL] [Abstract] [Full Text] [Related]
10. [Curative radiotherapy in stage C prostatic carcinoma. Experiences with radiotherapy-endocrine treatment].
Klosterhalfen H; Becker H; Köllermann MW; Altenähr E
Urologe A; 1983 Sep; 22 Suppl():360-6. PubMed ID: 6314624
[TBL] [Abstract] [Full Text] [Related]
11. A comparison of cancer survival by time period of diagnosis in Hawaii, 1960-1974.
Hinds MW; Nomura AM; Kolonel LN; Lee J
Cancer; 1983 Jan; 51(1):175-8. PubMed ID: 6821802
[TBL] [Abstract] [Full Text] [Related]
12. The management of transitional cell carcinoma in the prostate.
Wolfe JH; Lloyd-Davies RW
Br J Urol; 1981 Jun; 53(3):253-7. PubMed ID: 7248704
[TBL] [Abstract] [Full Text] [Related]
